|2nd December 2020||Israel Gp Ltd. Orbi Med||103,200||Open or private sale||$21.60||$2,229,120.00|
|27th November 2020||John Temperato||203,667||Grant/award etc.||$0.00|
|9th November 2020||Lorin K Johnson||4,262||Exercise of in-the-money or at-the-money derivatives securities (usually options)||$4.00||$17,048.00|
|30th October 2020||Israel Gp Ltd. Orbi Med||1,943,734||Other acquisition or disposition||$0.00|
|30th October 2020||Nissim Darvish||1,943,734||Other acquisition or disposition||$0.00|
|30th October 2020||Mark A Sirgo||4,513||Other acquisition or disposition||$0.00|
|30th October 2020||John Temperato||4,513||Other acquisition or disposition||$0.00|
|11th September 2020||Mark A Sirgo||21,485||Open or private purchase||$0.65||$14,003.92|
|11th September 2020||Mark A Sirgo||77,000||Open or private purchase||$0.68||$52,360.00|
|10th September 2020||Mark A Sirgo||50,000||Open or private purchase||$0.60||$30,000.00|
Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 10/10.
Innovate Biopharmaceuticals, Inc. is a clinical-stage biopharm Pharmaceutical company. The company is founded by Jay P. Madan and Kendyle Woodard in 2012.